Skip to main content
SpringerLink
Log in

Exjade linked to hepatic failure

  • News item
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

REFERENCE

  1. Health Canada.SUBJECT: Reports of severe liver problems with EXJADE* (deferasirox). Media Release: 7 Mar 2008. Available from: URL: http://www.hc-sc.gc.ca

  2. Novartis Pharmaceuticals Canada Inc.Reports of hepatic failure with EXJADE* (deferasirox). Internet Document: [3 pages], 4 Mar 2008. Available from: URL: http://www.hc-sc.gc.ca

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Exjade linked to hepatic failure. React. Wkly. 1193, 2 (2008). https://doi.org/10.2165/00128415-200811930-00003

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00128415-200811930-00003

Keywords

Search

Navigation